Alzamend Neuro, Inc. (ALZN) earnings

ALZN earnings moved a median of -1.47% by the close. Quarterly and annual ALZN reports and results, each read against the price at its own news timestamp. Back to the ALZN overview →

15 measured ALZN earnings events.

Where these ALZN earnings landedvs 15 measured ALZN earnings reactions
ALZN earningsMiddle 50% · -3.16% to +0.85%Zero: 0.00%Median: -1.47%Median -1.47%-4.00%0+4.00%
Middle 50% of ALZN earnings reactions-3.16% to +0.85%
Median reaction (to close)-1.47%
Measured reactions15
Point-in-time · zero look-ahead

Half of the 15 ALZN earnings events with a measured close landed between -3.16% and +0.85%; 33% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Alzamend Neuro, Inc. For: Jul 31SEC filing · Form 10-Q-2.40%+2.99%
Form 10-K Alzamend Neuro, Inc. For: Apr 30SEC filing · Form 10-K+0.00%-3.82%
Form 10-Q Alzamend Neuro, Inc. For: Jan 31SEC filing · Form 10-Q+0.00%-2.79%
Form 10-Q Alzamend Neuro, Inc. For: Oct 31SEC filing · Form 10-Q+1.84%-0.46%
Form 10-Q Alzamend Neuro, Inc. For: Jul 31SEC filing · Form 10-Q+2.61%+4.35%
Form 10-K Alzamend Neuro, Inc. For: Apr 30SEC filing · Form 10-K+0.55%-3.53%
Form 10-Q Alzamend Neuro, Inc. For: Jan 31SEC filing · Form 10-Q+0.00%-2.45%
Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical ProgramsPress release-0.61%+0.85%
Form 10-Q Alzamend Neuro, Inc. For: Oct 31SEC filing · Form 10-Q-0.61%+0.85%
Form 10-Q Alzamend Neuro, Inc. For: Jul 31SEC filing · Form 10-Q+0.98%-0.98%
Form 10-K Alzamend Neuro, Inc. For: Apr 30SEC filing · Form 10-K+0.00%-5.05%
Form NT 10-K Alzamend Neuro, Inc. For: Apr 30SEC filing · Form NT—-14.78%
Form 10-Q Alzamend Neuro, Inc. For: Jan 31SEC filing · Form 10-Q-0.99%-1.47%
Form NT 10-Q Alzamend Neuro, Inc. For: Jan 31SEC filing · Form NT—+9.74%
Form 10-Q Alzamend Neuro, Inc. For: Oct 31SEC filing · Form 10-Q+0.00%-1.96%
That’s how ALZN usually reacts to earnings — get an email when it moves on news →
Keep exploring

More ALZN: analyst actions → · SEC filings → · ALZN overview →